HazMat Fee + There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
| Type | HazMat fee for 500 gram (Estimated) |
| Excepted Quantity | USD 0.00 |
| Limited Quantity | USD 15-60 |
| Inaccessible (Haz class 6.1), Domestic | USD 80+ |
| Inaccessible (Haz class 6.1), International | USD 150+ |
| Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
| Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} {[ size_append(item.pr_size_append, item.pr_am, item.pr_size) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| Concentration | Treated Time | Description | References | |
| BHK cells | 100 μM | 18 h | To investigate the effect of PUGNAc on Akt1 glycosylation and phosphorylation. Results showed that PUGNAc treatment led to accumulation of O-GlcNAc proteins and caused hypophosphorylation of Akt T308. | Nat Cell Biol. 2010 Sep;12(9):876-85 |
| Neonatal rat cardiac myocytes (NRCMs) | 200 µM | overnight | Inhibition of O-GlcNAcase activity, increased O-GlcNAc levels, and reduced post-hypoxic cardiac myocyte death | Circ Res. 2009 Jan 2;104(1):41-9 |
| vascular smooth muscle cells (VSMCs) | 100 μM | 24 h | To investigate the effect of PugNAc on vascular reactivity to phenylephrine. PugNAc increased vascular reactivity to phenylephrine, which was abolished by the Rho kinase inhibitor Y-27632 | Cardiovasc Res. 2011 Feb 15;89(3):614-22 |
| 3T3-L1 adipocytes | 100 μM | 16 h | Increased O-GlcNAc levels by inhibiting O-GlcNAcase, leading to insulin resistance | Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5313-8 |
| second-order mesenteric arteries | 100µM | 24 h | increased vascular O-GlcNAc-protein content, enhanced PE-induced vascular contraction, and reduced ACh-induced vasodilation | Hypertension. 2009 Feb;53(2):166-74 |
| human retinal micro vascular endothelial cells (HRECs) | 200 µM | 12 h | To investigate the association between O-GlcNAcylation and ROS generation, it was found that PUGNAc significantly attenuated the production of ROS (P<0.01) and increased the expression levels of antioxidant genes SOD and GPX. | Int J Mol Med. 2015 Oct;36(4):1019-27 |
| Administration | Dosage | Frequency | Description | References | ||
| Mice | K18 Gly− transgenic mice | Intraperitoneal injection | 7 mg/kg | Fas antibody injection after 48 hours | To investigate the effect of combined PUGNAc and Fas treatment on K18 Gly? mice. Results showed that K18 Gly? mice were more susceptible to PUGNAc/Fas-induced injury, with increased liver hemorrhage, apoptosis, and decreased Akt1 T308 phosphorylation. | Nat Cell Biol. 2010 Sep;12(9):876-85 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.83mL 0.57mL 0.28mL |
14.15mL 2.83mL 1.42mL |
28.30mL 5.66mL 2.83mL |
|
| CAS号 | 132489-69-1 |
| 分子式 | C15H19N3O7 |
| 分子量 | 353.33 |
| SMILES Code | CC(N[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O/1)C1=N\OC(NC2=CC=CC=C2)=O)=O |
| MDL No. | MFCD00145022 |
| 别名 | |
| 运输 | 蓝冰 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, inert atmosphere, store in freezer, under -20°C |
| 溶解方案 |
DMSO: 50 mg/mL(141.51 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1